(Q34240923)

31 July 2017

1 reference

title

Applications of pharmacogenetics in psychiatry: personalisation of treatment (English)

1 reference

31 July 2017

0 references

Arranz MJ

1

1 reference

31 July 2017

Munro J

2

1 reference

31 July 2017

Osborne S

3

1 reference

31 July 2017

Collier D

4

1 reference

31 July 2017

Kerwin RW

5

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

Expert Opinion on Pharmacotherapy

31 July 2017

1 reference

31 July 2017

2

1 reference

31 July 2017

4

1 reference

31 July 2017

537-542

1 reference

Neurotransmitter-related genes and antipsychotic response: pharmacogenetics meets psychiatric treatment

31 July 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.537

Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.537

Extreme discordant phenotype methodology: an intuitive approach to clinical pharmacogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.537

Pharmacogenetics and psychopharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.537

Molecular mechanisms of genetic polymorphisms of drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.537

Polymorphic cytochromes P450 and drugs used in psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.537

Catalytic activity of three variants (Ile, Leu, and Thr) at amino acid residue 359 in human CYP2C9 gene and simultaneous detection using single-strand conformation polymorphism analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.537

Pharmacogenomics and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.537

Association of the dopamine transporter gene (DAT1) with poor methylphenidate response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.537

Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.537

Association of the MscI polymorphism of the dopamine D3 receptor gene with tardive dyskinesia in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.537

Ser9Gly dopamine D3 receptor polymorphism and spontaneous dyskinesia in never-medicated schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.537

A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: association with tardive dyskinesia in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.537

An association between clozapine-induced agranulocytosis in schizophrenics and HLA-DQB1*0201.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.537

HLA-B38 and clozapine-induced agranulocytosis in Israeli Jewish schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.537

Polymorphisms of the dopamine D4 receptor and response to antipsychotic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.537

Pharmacogenetic prediction of clozapine response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.537

Analysis of a structural polymorphism in the 5-HT2A receptor and clinical response to clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.4.537

21 January 2018

Identifiers

DOI

10.1517/14656566.2.4.537

1 reference

31 July 2017

1 reference